An Evaluation of the Clinical Utility and Safety of the Visant Medical Canalicular Plug
NCT04817085 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156
Last updated 2022-06-06
Summary
This study is designed to evaluate the clinical utility and safety of the Visant Medical Canalicular Plug compared to a commercially available canalicular plug.
Conditions
- Dry Eye
Interventions
- DEVICE
-
Visant Medical Canalicular Plug
Plug is inserted into the inferior canaliculi and assessed for 6 months
- DEVICE
-
Commercially available canalicular plug
Plug is inserted into the inferior canaliculi and assessed for 6 months
Sponsors & Collaborators
-
Visant Medical, Inc.
lead INDUSTRY
Principal Investigators
-
Roger Albright · Ora Clinical Research Organization
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-06
- Primary Completion
- 2022-02-09
- Completion
- 2022-02-09
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal Users
NCT04763018 ·Status: UNKNOWN ·Phase: NA
-
Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease
NCT04143841 ·Status: TERMINATED ·Phase: NA
-
Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer
NCT00557362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease
NCT04498182 ·Status: COMPLETED ·Phase: PHASE2
-
LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease
NCT02365519 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness
NCT03645850 ·Status: UNKNOWN ·Phase: NA
-
Study of OT202 in Treating Moderate to Severe Dry Eye
NCT06435182 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of Therapeutic Meibomian Gland Expression
NCT04997135 ·Status: COMPLETED
-
Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation
NCT02385292 ·Status: COMPLETED ·Phase: NA
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00403715 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye
NCT00037661 ·Status: COMPLETED ·Phase: PHASE3
-
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT00404131 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye
NCT00799552 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye
NCT01791426 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
NCT03636061 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
NCT01877694 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray
NCT05514041 ·Status: COMPLETED ·Phase: PHASE4
-
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye
NCT06696625 ·Status: RECRUITING ·Phase: NA
-
Evaluating a Device for Blocking the Tear Duct
NCT05748951 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
NCT00836485 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model
NCT00814944 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis
NCT03749317 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation
NCT02910713 ·Status: COMPLETED ·Phase: NA
-
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease With Meibomian Gland Dysfunction
NCT06544447 ·Status: RECRUITING ·Phase: PHASE1/PHASE2